Literature DB >> 23111933

'Sea legs': sharpened Romberg test after three days on a live-aboard dive boat.

Clinton R Gibbs1, Katherine H Commons, Lawrence H Brown, Denise F Blake.   

Abstract

INTRODUCTION: The sharpened Romberg test (SRT) is commonly used by diving and hyperbaric physicians as an indicator of neurological decompression illness (DCI). People who spend a prolonged time on a boat at sea experience impairment in their balance on returning to shore, a condition known as mal de debarquement ('sea legs'). This conditioning of the vestibular system to the rocking motion of a boat at sea may impact on the utility of the SRT in assessing a diver with potential DCI after a live-aboard dive trip. AIM: To assess the impact 'sea legs' has on the SRT after three days on a live-aboard dive trip.
METHODS: Thirty-nine staff and passengers of a three-day, live-aboard dive trip performed a SRT before and after their journey, with assessment of potential variables, including middle ear barotrauma, alcohol consumption, sea-sickness and occult DCI.
RESULTS: There was no statistically significant impact on SRT performance, with 100% completion pre-trip and 35 out of 36 divers (97.2%) post-trip. There were trends towards more attempts being required and time needed for successful SRT post-trip, but these were not statistically significant. There was a small, but noteworthy incidence of middle-ear barotrauma, with seven people affected pre-trip, and 13 post-trip. There was a higher incidence in student divers. Middle-ear barotrauma did not appear to have a direct impact on SRT performance.
CONCLUSION: There was no significant impact on SRT performance resulting from 'sea legs' after three days at sea. Recreational divers, especially dive students, have a substantial incidence of mild middle ear barotrauma.

Entities:  

Year:  2010        PMID: 23111933

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  1 in total

Review 1.  Mal de debarquement syndrome: a systematic review.

Authors:  Angelique Van Ombergen; Vincent Van Rompaey; Leen K Maes; Paul H Van de Heyning; Floris L Wuyts
Journal:  J Neurol       Date:  2015-11-11       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.